Nifedipine inhibits apoptotic cell death of cultured endothelial cells induced by tumor necrosis factor-α

Drugs under Experimental and Clinical Research

Volumn 29, Issue 4, 2003, Pages 141-145

  Yamagishi, Sho Ichi ^a   Inagaki, Y ^a   Abe, R ^b   Kikuchi, S ^b   Sasaki, N ^c   Takeuchi, M ^d  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; NIFEDIPINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN SYNTHESIS; UMBILICAL VEIN;

ACETYLCYSTEINE; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FREE RADICAL SCAVENGERS; HUMANS; NIFEDIPINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1442338444     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. Endothelial apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell Cardiol., 33, 1673, 2001.
2. Ross R. Atherosclerosis: An inflammatory disease. N. Eng. J. Med., 340, 115, 1999.
3. Introna M., Mantovani A. Early activation signals in endothelial cells. Arterioscler. Thromb. Vasc. Biol., 17, 423, 1997.
4. Manitovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB J., 6, 2591, 1992.
5. Zhang W.J., Frei B. Alpha-lipoic acid inhibits TNF-α-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J., 15, 2423, 2001.
6. Vanden Berghe W., Vermeulen L., De Wilde G., De Bosscher K., Boone E., Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol., 60, 1185, 2000.
7. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor-alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type. J. Exp. Med., 177, 1277, 1992.
8. Nawroth P.P., Stern D.M. Modulation of endothelial cells hemostatic properties by tumor necrosis factor. J. Exp. Med., 163, 740, 1986.
9. Saeed R.W., Peng T., Metz C.N. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-α on endothelial cells. Exp. Biol. Med., 228, 855, 2003.
10. Taddei S., Virdis A., Ghiadoni L., Sudanom I., Salvetti A. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. Curr. Hypertens. Rep., 2, 64, 2000.
11. Taddei S., Virdis A., Ghiadoni L., et al. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J. Hypertens., 19, 1379, 2001.
12. Zanchetti A., Bond M.G., Hennig M., et al. European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation, 106, 2422, 2002.
13. Yamagishi S., Inagaki Y., Kikuchi S. Nifedipine inhibits tumor necrosis factor-α-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation. Drugs Exp. Clin. Res., 29(4), 147, 2003.
14. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int., 62, 464, 2003.
15. Yamagishi S., Inagaki Y., Amano S., et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J. Biol. Chem., 277, 20309, 2002.
16. Rossig L., Hoffmann J., Hugel B., et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation, 104, 2182, 2001.
17. Sugano M., Tsuchida K., Makino N. Nifedipine prevents apoptosis of endothelial cells induced by oxidized low-density lipoproteins. J. Cardiovasc. Pharmacol., 40, 146, 2002.
18. Bruunsgaard H., Skinhoj P., Pedersen A.N., Schroll M., Pedersen B.K. Ageing, tumor necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol., 121, 255, 2000.
19. Vehaar M.C., Honing M.L., van Dam T., et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc. Res., 42, 752, 1999.
20. Ramsch K.D., Ziegler R. Plasma concentrations of various nifedipine formulations in healthy volunteers. Sixth International Adalat Symposium. Excepta Medica, 23, 1986, p. 23.
21. Herbette L.G., Vant Erve YM., Rhodes D.G. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors. J. Mol. Cell Cardiol., 21, 187, 1989,
22. Fukuo K., Yang J., Yasuda O., et al. Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways. Circulation, 106, 356, 2002.